
Olema Oncology Jobs in United States
51 jobs at Olema Oncology in United States
-
Join to apply for the Director, Clinical Monitoring Oversight role at Olema Oncology · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently i ...
San Francisco4 days ago
-
Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...
San Francisco1 day ago
-
Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. This Senior Director of Clinical Business Operations will support the Clinical Department's initiatives to contribute to the success of our clinical trials. · ...
Boston1 month ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
San Francisco, California2 days ago
-
Join to apply for the Director, Analytical Development role at Olema Oncology · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in devel ...
San Francisco4 days ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
San Francisco, California2 days ago
-
Olema Oncology is developing medicines for breast cancer. · We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. · This role will provide strategic direction and operational oversight of all global monitoring activities across Olema's c ...
San Francisco, CA2 weeks ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
San Francisco, California3 days ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
San Francisco, California2 days ago
-
Senior Manager GCP Quality Assurance · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. · Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer wit ...
San Francisco1 week ago
-
A leading biotechnology company is seeking a Director of Analytical Development in San Francisco. In this role, you will oversee analytical method innovations and ensure compliance with regulatory standards for drug development. The ideal candidate has substantial experience in a ...
San Francisco4 days ago
-
Job Overview · We are seeking a Senior Manager, Global Regulatory Affairs Strategy who will provide regulatory strategy support in partnership with cross-functional teams and subject matter experts and manage regulatory aspects through all phases of development. · About You · You ...
San Francisco1 week ago
-
Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...
Boston1 week ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
Boston, Massachusetts1 day ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
San Francisco, California2 days ago
-
Director of Facilities · Olema Oncology aims to develop innovative medicines for breast cancer treatment. · We are looking for a Director of Facilities who will lead our facilities operations and laboratory environments across multiple sites. · ...
San Francisco3 days ago
-
· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...
Boston, Massachusetts3 days ago
-
+Job summary · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. · +Lead the development of the New Drug Application (NDA) · Develop innovative global regulatory strategies for the Olema portfolio of products in clinical development and life ...
San Francisco, CA4 weeks ago
-
Job Title: Director, Analytical Development · Olema Oncology develops better medicines for breast cancer and beyond. · The Director of Analytical Development will oversee analytical method development, qualification, and validation. · Responsibilities include conducting technical ...
Boston1 day ago
-
Olema Oncology es una empresa dedicada a desarrollar medicinas mejoradas para el cáncer de seno y más allá. Nuestro programa principal, palazestrant (OP-1250), es un antagonista completo del receptor de estrógeno (CERAN) actualmente en desarrollo para el cáncer de seno metastátic ...
San Francisco, CA1 month ago